MedPath

POLYSAN Scientific & Technological Pharmaceutical Company

Ownership
Private
Employees
-
Market Cap
-
Website

Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome

Phase 2
Terminated
Conditions
Non-alcoholic Fatty Liver Disease
Interventions
Drug: Runihol
Other: Placebo
First Posted Date
2016-10-12
Last Posted Date
2019-02-08
Lead Sponsor
POLYSAN Scientific & Technological Pharmaceutical Company
Target Recruit Count
35
Registration Number
NCT02930161
Locations
🇷🇺

Medical Company "Hepatologist" Ltd., Samara, Russian Federation

🇷🇺

Company "Clinic of professor Gorbakov" Ltd., Krasnogorsk, Russian Federation

🇷🇺

City Hospital of the Holy Martyr Elizabeth, Saint-Petersburg, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath